[Federal Register Volume 74, Number 97 (Thursday, May 21, 2009)]
[Notices]
[Pages 23866-23867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11698]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting

    The National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK), on behalf of the National Institutes of Health (NIH), 
the Centers for Disease Control and Prevention (CDC), and the Diabetes 
Mellitus Interagency Coordinating Committee (DMICC), is convening an ad 
hoc planning and evaluation meeting to provide a mid-course assessment 
of ongoing pre-clinical research efforts supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research and to discuss 
possible future directions for these efforts.
    Sessions of the meeting will be open to the public as indicated 
below, with attendance limited to space available. Certain sessions, 
during which confidential information will be discussed, will be closed 
to the public. Members of the public planning to attend the meeting 
must register online at: http://www.scgcorp.com/Type1Diabetes09/registration.asp. This is not a meeting to solicit public comment. 
Therefore, members of the public are permitted to attend the open 
sessions as observers only. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should inform the Contact Person listed 
below at least 10 days in advance of the meeting.
    Name: Meeting on Pre-Clinical Research Supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research.
    Place: National Institutes of Health, Neuroscience Building, 6001 
Executive Blvd., Conference Room C, Bethesda, MD 20852.
    Date: June 17, 2009.
    Open: 8 a.m. to 8:45 a.m.
    Agenda: Meeting introduction; overview of the Type 1 Diabetes--
Rapid Access to Intervention Development (T1D-RAID) research program.
    Closed: 8:45 a.m. to 9:30 a.m.
    Agenda: Mid-course assessment of T1D-RAID.
    Open: 9:30 a.m. to 10 a.m.
    Agenda: Overview of the Type 1 Diabetes Preclinical Testing Program 
(T1D-PTP)--Prevention or Reversal of Type 1 Diabetes in Rodent Models.
    Closed: 10 a.m. to 10:30 a.m.
    Agenda: Mid-course assessment of the T1D-PTP--Prevention or 
Reversal of Type 1 Diabetes in Rodent Models.
    Open: 10:45 a.m. to 11:15 a.m.
    Agenda: Overview of the T1D-PTP--Prevention or Reversal of Diabetic 
Complications in Rodent Models.
    Closed: 11:15 a.m. to 11:45 a.m.
    Agenda: Mid-course assessment of the T1D-PTP--Prevention or 
Reversal of Diabetic Complications in Rodent Models.
    Open: 12:30 p.m. to 1 p.m.
    Agenda: Overview of the Animal Models of Diabetic Complications 
Consortium (AMDCC) research program.
    Closed: 1 p.m. to 2 p.m.
    Agenda: Mid-course assessment of the AMDCC.
    Open: 2 p.m. to 2:30 p.m.
    Agenda: Overview of the Type 1 Diabetes Resource.
    Closed: 2:30 p.m. to 3:15 p.m.
    Agenda: Mid-course assessment of the Type 1 Diabetes Resource.
    Open: 3:30 p.m. to 4 p.m.
    Agenda: Overview of Beta Cell Biology Consortium (BCBC).
    Closed: 4 p.m. to 5 p.m.
    Agenda: Mid-course assessment of the BCBC.
    Contact Person: Julie Wallace, PhD, Health Science Policy Analyst, 
Office of Scientific Program and Policy Analysis, National Institute of 
Diabetes and Digestive and Kidney Diseases, 9000 Rockville Pike, 
Building 31, Room 9A05, Bethesda, MD 20892, (301) 496-6623, 
[email protected].


[[Page 23867]]


    Name: Meeting on Pre-Clinical Research Supported by the Special 
Statutory Funding Program for Type 1 Diabetes Research.
    Place: National Institutes of Health, Neuroscience Building, 6001 
Executive Blvd., Conference Room C, Bethesda, MD 20852.
    Date: June 18, 2009.
    Open: 8 a.m. to 8:30 a.m.
    Agenda: Overview of the Cooperative Study Group for Autoimmune 
Disease Prevention (Prevention Centers) research program.
    Closed: 8:30 a.m. to 9 a.m.
    Agenda: Mid-course assessment of the Prevention Centers.
    Open: 9 a.m. to 9:30 a.m.
    Agenda: Overview of the Immunobiology of Xenotransplantation 
Cooperative Research Program (IXCRP) research program.
    Closed: 9:30 a.m. to 10:15 a.m.
    Agenda: Mid-course assessment of the IXCRP.
    Open: 10:30 a.m. to 11 a.m.
    Agenda: Overview of the NHP Transplantation Tolerance Cooperative 
Study Group (NHPCSG).
    Closed: 11 a.m. to 12:15 p.m.
    Agenda: Mid-course assessment of the NHPCSG; discussion of cross-
cutting themes for strengthening the ongoing preclinical research 
portfolio.
    Open: 12:30 p.m. to 1:30 p.m.
    Agenda: Discussion of future opportunities for preclinical 
research.
    Contact Person: Julie Wallace, PhD, Health Science Policy Analyst, 
Office of Scientific Program and Policy Analysis, National Institute of 
Diabetes and Digestive and Kidney Diseases, 9000 Rockville Pike, 
Building 31, Room 9A05, Bethesda, MD 20892, (301) 496-6623, 
[email protected].

    Please Note: The NIH has instituted security measures to ensure 
the safety of NIH employees and property. Upon your arrival at the 
Neuroscience Building, enter through the main lobby where you will 
be greeted at the security guard's desk. Visitors who are not NIH 
employees will be required to show one form of identification (for 
example, a government-issued photo ID, driver's license, or 
passport) and to have their bags searched in order to enter the 
building. You will then be issued a visitor badge. In estimating 
your travel time, please allow for these security measures, 
particularly if you are arriving in a group. Self-parking is 
available for a maximum of $8 per day.

    A registration link, information about the meeting, and the agenda 
are available online: http://www3.niddk.nih.gov/fund/otherType1Diabetes09/.

    Dated: May 12, 2009.
Sanford Garfield,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and 
Metabolic Diseases, NIDDK, National Institutes of Health.
[FR Doc. E9-11698 Filed 5-20-09; 8:45 am]
BILLING CODE 4140-01-M